Inventor profile of:

Viktor Levitski

City:

Schlieren

Country:

Switzerland

Published Applications:

22

Last publication date:

2025-03-27

Top Assignees for applications by Viktor Levitski

The entities that hold a legal rights for patent applications filed by inventor Levitski Viktor:

Recent patent applications by Levitski Viktor

Viktor Levitski from Schlieren, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27
US20250101135A1
Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#2 | 2023-11-09
US20230357397A1
Chemistry; metallurgy

COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS

#3 | 2023-04-20
US20230123178A1
Chemistry; metallurgy

Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety

#4 | 2022-08-25
US20220267395A1
Chemistry; metallurgy

Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof

#5 | 2022-08-18
US20220259327A1
Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#6 | 2022-08-18
US20220259326A1
Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

#7 | 2022-08-18
US20220259314A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES SPECIFIC FOR PD1 AND TIM3

#8 | 2022-03-10
US20220073646A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

#9 | 2020-10-15
US20200325225A1
Chemistry; metallurgy

COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS

#10 | 2020-08-27
US20200270321A1
Chemistry; metallurgy

ANTIGEN BINDING MOLECULES COMPRISING A TRIMERIC TNF FAMILY LIGAND

#11 | 2020-08-06
US20200247904A1
Chemistry; metallurgy

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

#12 | 2020-03-05
US20200071411A1
Chemistry; metallurgy

Bispecific antibodies specific for OX40

#13 | 2019-12-19
US20190382507A1
Chemistry; metallurgy

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

#14 | 2019-10-24
US20190322748A1
Chemistry; metallurgy

Bispecific antibodies specific for PD1 and TIM3

#15 | 2019-08-15
US20190248877A1
Chemistry; metallurgy

Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety

#16 | 2019-07-11
US20190211113A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

#17 | 2019-06-20
US20190185566A1
Chemistry; metallurgy

Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety

#18 | 2017-08-31
US20170247467A1
Chemistry; metallurgy

BISPECIFIC ANTIBODIES WITH TETRAVALENCY FOR A COSTIMULATORY TNF RECEPTOR

#19 | 2017-04-27
US20170114141A1
Chemistry; metallurgy

Bispecific antibodies specific for OX40

#20 | 2017-04-27
US20170114135A1
Chemistry; metallurgy

Bispecific antibodies specific for PD1 and TIM3

#21 | 2016-11-24
US20160340399A1
Chemistry; metallurgy

Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules

#22 | 2016-07-14
US20160200833A1
Chemistry; metallurgy

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

InventorID:

1717254 ⎘